Marshall Wace, LLP Iradimed Corp Transaction History

Marshall Wace, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.36 - $44.7 $425,031 - $470,735	10,531 New	10,531 $462,000
Q2 2022 Aug 15, 2022	SELL	$30.15 - $45.79 $164,588 - $249,967	-5,459 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$36.01 - $53.14 $1.05 Million - $1.55 Million	-29,121 Reduced 84.21%	5,459 $246,000
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $1.12 Million - $1.67 Million	34,580 New	34,580 $1.6 Million
Q2 2020 Aug 13, 2020	SELL	$18.68 - $24.35 $708,046 - $922,962	-37,904 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.08 - $27.67 $455,353 - $783,559	-28,318 Reduced 42.76%	37,904 $809,000
Q4 2019 Feb 14, 2020	SELL	$21.11 - $25.92 $767,052 - $941,829	-36,336 Reduced 35.43%	66,222 $1.55 Million
Q3 2019 Nov 14, 2019	BUY	$18.06 - $24.1 $508,244 - $678,222	28,142 Added 37.82%	102,558 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$19.6 - $29.31 $1.29 Million - $1.93 Million	65,819 Added 765.6%	74,416 $1.52 Million
Q1 2019 May 14, 2019	BUY	$23.58 - $28.43 $202,717 - $244,412	8,597 New	8,597 $241,000

140

6.59M

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $679M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.